Who
Adam K. Stern
Director
Company insider
Files Form 4 as: Director, DarioHealth; Director and 10% owner, Matinas Biopharma Holdings; Director, VivoSim Labs; Director, PROLOR Biotech; Director, Invivo Therapeutics Holdings.
In numbers
- Trades disclosed
- 118
- Buys
- 29
- Sells
- 2
- Bought
- $540K
- Sold
- $3.1M
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 26 Sep 2008
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $50K141,462 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code X | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code X | $221K630,335 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | $221K630,335 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | $221K630,335 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code J | $50K141,462 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | $221K630,335 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | $221K630,335 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code X | $121K344,710 at $0.35 | filing |
| 10 Jul 2026filed 13 Aug 2026 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code X | $221K630,335 at $0.35 | filing |
| 27 Jan 2026filed 29 Jan 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 31 Oct 2025filed 13 Aug 2026 | MTNB Matinas Biopharma HoldingsBiotechnology | SEC FORM 4 Code X | $59K92,100 at $0.6446 | filing |
| 31 Oct 2025filed 13 Aug 2026 | MTNB Matinas Biopharma Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code X | $59K92,100 at $0.64 | filing |
News
Matinas Biopharma Holdings, Inc. (NYSEAMERICAN:MTNB) Shares Shorted: Short Interest Down 87.3% in SeptemberMTNB · dailypolitical.com · 12 Oct 2026
0 headlines in the last 90 days name Adam K. Stern; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.